Cargando…
A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study
SIMPLE SUMMARY: Prostate cancer (PCa) is the second most common malignancy in males globally. Although PSA screening is a milestone in PCa detection, it also causes overdiagnosis and subsequent overtreatment. Therefore, it is imperative to find an optimal replacement or supplement for PSA testing to...
Autores principales: | Li, Yun, Ji, Jin, Lyu, Ji, Jin, Xin, He, Xing, Mo, Shaojia, Xu, Huan, He, Jingyi, Cao, Zhi, Chen, Xi, Xu, Yalong, Wang, Lei, Wang, Fubo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393262/ https://www.ncbi.nlm.nih.gov/pubmed/34439239 http://dx.doi.org/10.3390/cancers13164075 |
Ejemplares similares
-
Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022) -
Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer
por: Ji, Jin, et al.
Publicado: (2021) -
Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based
α-Methylacyl-CoA Racemase Score: A Single-Center Experience
por: Ji, Jin, et al.
Publicado: (2019) -
Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020) -
FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020)